GetTopicDetailResponse(id=6f5534906a, topicName=BITA, introduction=BITA, content=null, image=null, comments=4, allHits=760, url=https://h5.medsci.cn/topic?id=3490, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=88527, tagList=[TagDto(tagId=88527, tagName=BITA)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1780344, encodeId=ddfa1e803447a, content=<a href='/topic/show?id=6f5534906a' target=_blank style='color:#2F92EE;'>#BITA#</a>, objectTitle=EuroPCR2018丨ORBITA生理學(xué)分層研究：FFR、iFR引領(lǐng)PCI新方向, objectType=article, longId=139239, objectId=659a139239c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=659a139239c9, replyNumber=0, likeNumber=107, createdTime=2018-09-21, rootId=0, userName=124987c6m36暫無昵稱, userId=85152500072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=659a139239c9, moduleTitle=EuroPCR2018丨ORBITA生理學(xué)分層研究：FFR、iFR引領(lǐng)PCI新方向, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=659a139239c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780343, encodeId=d3c91e80343ef, content=<a href='/topic/show?id=6f5534906a' target=_blank style='color:#2F92EE;'>#BITA#</a>, objectTitle=Liver Int：ombitasvir, paritaprevir/r+dasabuvir+ribavirin治療HCV基因1b型肝硬化患者的真實(shí)療效和安全性, objectType=article, longId=135698, objectId=b97d1356989d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b97d1356989d, replyNumber=0, likeNumber=83, createdTime=2018-10-21, rootId=0, userName=124987c6m36暫無昵稱, userId=85152500072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b97d1356989d, moduleTitle=Liver Int：ombitasvir, paritaprevir/r+dasabuvir+ribavirin治療HCV基因1b型肝硬化患者的真實(shí)療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b97d1356989d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780341, encodeId=2eaf1e80341e7, content=<a href='/topic/show?id=6f5534906a' target=_blank style='color:#2F92EE;'>#BITA#</a>, objectTitle=Liver Int ：ombitasvir, Paritaprevir/+Dasabuvir+Ribavirin對(duì)基因1b型丙型肝炎肝硬化患者的療效和安全性分析, objectType=article, longId=110983, objectId=fd4a11098334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd4a11098334, replyNumber=0, likeNumber=132, createdTime=2017-11-13, rootId=0, userName=124987c6m36暫無昵稱, userId=85152500072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd4a11098334, moduleTitle=Liver Int ：ombitasvir, Paritaprevir/+Dasabuvir+Ribavirin對(duì)基因1b型丙型肝炎肝硬化患者的療效和安全性分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fd4a11098334)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780342, encodeId=bc191e80342b5, content=<a href='/topic/show?id=6f5534906a' target=_blank style='color:#2F92EE;'>#BITA#</a>, objectTitle=J Viral Hepat：采用Paritaprevir/Ombitasvir/Ritonavir, Dasabuvir和Ribavirin等藥物治療HBV和H, objectType=article, longId=129423, objectId=33a2129423ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33a2129423ba, replyNumber=0, likeNumber=100, createdTime=2019-01-17, rootId=0, userName=124987c6m36暫無昵稱, userId=85152500072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33a2129423ba, moduleTitle=J Viral Hepat：采用Paritaprevir/Ombitasvir/Ritonavir, Dasabuvir和Ribavirin等藥物治療HBV和H, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=33a2129423ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
